关于环胺代谢和抗癌作用机制的见解:一项计算研究
Eslam Dabbish1, Stefano Scoditti2, Mohammed N I Shehata3
1Department of Chemistry, The American University in Cairo, New Cairo, Egypt.
Journal of computational chemistry
|December 13, 2023
概括
环胺 (CP) 是一种通过肝酶激活的化疗药物. 这项研究使用DFT来揭示CPCP.
科学领域:
- 计算化学计算化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 环胺 (CP) 是癌症化疗中重要的DNA化前药物.
- 肝炎需要代谢激活,主要是通过肝细胞染色体P450介导的4-氧化,才能产生细胞毒性作用.
- 了解CP的代谢途径和DNA化机制对于开发改进的oxazaphosphorine类似物至关重要.
研究的目的:
- 进行密度功能理论 (DFT) 调查对环胺 (CP) 的代谢激活.
- 阐明CP发挥其细胞毒性作用的机制,包括DNA化.
- 提供可以促进下一代酸抗癌剂设计的见解.
主要方法:
- 用密度函数理论 (DFT) 进行计算分析.
- 研究了所有代谢转换的能量概况.
- 分析了通过CP代谢产物对DNA化的详细机制.
主要成果:
- 对CP的代谢途径和激活的详细计算分析.
- 阐明控制CP转换的能源格局.
- 洞察通过活性代谢产物对DNA化特异性机制.
结论:
- 该DFT调查提供了全面了解环胺的新陈代谢和细胞毒性.
- 这些发现为CP的DNA化提供了有价值的机制性见解.
- 这些知识可以指导未来开发基于酸的新型化疗药物.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.5K
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.6K
相关概念视频
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:15M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K